Home » Topics » BioWorld Science

BioWorld Science
RSS

Dicerna begins phase II study of belcesiran for AAT deficiency-associated liver disease

June 22, 2021

Sanofi Pasteur and Translate Bio begin phase I trial of mRNA seasonal influenza vaccine

June 22, 2021

Anti-COX-2 Ab is a novel highly specific diagnostic marker in immune aplastic anemia

June 22, 2021

STING inhibitors target inflammatory diseases

June 22, 2021

Results from first-in-human study of AO-176 in advanced solid tumors

June 22, 2021

Stimulation of optic nerve activity increases optic glioma growth in mice with Nf1 mutations

June 22, 2021

Phase II trial of Auxora in patients with acute pancreatitis and accompanying SIRS and hypoxemia

June 22, 2021

Initial phase I data on Betalutin in relapsed/refractory DLBCL

June 22, 2021

Promising data reported from CYAD-211 IMMUNICY-1 trial

June 22, 2021

City of Hope National Medical Center presents FIH data on COH04S1 vaccine

June 22, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...